NGNE
Neurogene·NASDAQ
--
--(--)
--
--(--)
3.74 / 10
Netural
Analyst coverage is thin: one Strong Buy from Canaccord Genuity, but historical win rate is 0% and market expectation is pessimistic as price fell 5.66%. Fund‑flow score is 7.48 (good); overall inflow ratio ~0.49, small investors positive, larger investors negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionCanaccord Genuity
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for NGNE?
- NGNE holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.74/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
